Amphotericin B Treatment in Visceral Leishmaniasis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is being conducted to assess the safety and efficacy of amphotericin B
deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given
in the conventional way every alternate day against the daily administration regimen being
tested.
Phase:
N/A
Details
Lead Sponsor:
Banaras Hindu University
Treatments:
Amphotericin B Amphotericin B, deoxycholate drug combination Deoxycholic Acid Liposomal amphotericin B